Elon Musk Denies Reports Former Director Linda Johnson Left Tesla Over His Drug Use: 'No Negativity At All'
Portfolio Pulse from Anan Ashraf
Elon Musk, CEO of Tesla Inc (NASDAQ: TSLA), refuted claims that former director Linda Johnson Rice left the company due to his drug use. Musk stated that Johnson simply completed her term. The allegations of Musk's drug use, including substances like ketamine, LSD, cocaine, and ecstasy, were not investigated by the board. Musk also mentioned that he had undergone three years of random drug testing for NASA with no issues. He criticized the media outlet reporting these allegations.
January 09, 2024 | 4:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elon Musk's denial of drug use allegations and clarification regarding Linda Johnson Rice's departure from Tesla's board may reassure investors and mitigate negative sentiment.
Musk's response to the allegations could alleviate concerns among investors about leadership stability and corporate governance, which might have a positive impact on Tesla's stock in the short term. However, the impact may be moderate as the news pertains to past events and Musk's leadership has been consistently under scrutiny.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80